These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4269798)

  • 21. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitory effect of "late" type fibrinogen degradation products (FDP) upon the ethanol gelation of plasma.
    Sas G; Blaskó G; Jákó J; Bánhegyi D
    Haematologia (Budap); 1973; 7(3):369-74. PubMed ID: 4275193
    [No Abstract]   [Full Text] [Related]  

  • 23. Radioimmunoassay of fibrinogen and its proteolysis products.
    Catt KJ; Hirsh J; Castelan DJ; Niall HD; Tregear GW
    Thromb Diath Haemorrh; 1968 Nov; 20(1):1-6. PubMed ID: 4236937
    [No Abstract]   [Full Text] [Related]  

  • 24. Degradation of plasmin-resistant fibrinogen-fibrin breakdown products in rheumatoid synovial fluid by Brinastrase.
    Andersen RB; Gormsen J
    Scand J Rheumatol; 1973; 2(2):81-6. PubMed ID: 4270793
    [No Abstract]   [Full Text] [Related]  

  • 25. Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay.
    Gordon YB; Martin MJ; McNeile AT; Chard T
    Lancet; 1973 Nov; 2(7839):1168-70. PubMed ID: 4127547
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of intravascular and extravascular coagulation on serum fibrin degradation products in rats.
    Vanstone JC; Khoury NY
    Thromb Diath Haemorrh; 1971; 25(1):142-6. PubMed ID: 4996073
    [No Abstract]   [Full Text] [Related]  

  • 27. The Tanned Red Cell Hemagglutination Inhibition Immunoassay and purified fibrinogen degradation products.
    Donati MB; Molla A; Vermylen J
    Scand J Haematol Suppl; 1971; 13():91-9. PubMed ID: 4258208
    [No Abstract]   [Full Text] [Related]  

  • 28. [Application of immunologic methods and the Kissmeyer-Nielsen reaction for the detection of fibrinogen and the products of fibrinolysis].
    Gulmantowicz AH; Lodi R
    Schweiz Med Wochenschr; 1966 Sep; 96(37):1194-6. PubMed ID: 4967634
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
    Fisher S; Fletcher AP; Alkjaersig N; Sherry S
    J Lab Clin Med; 1967 Dec; 70(6):903-22. PubMed ID: 4228698
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of fibrinogen degradation products by use of antibody coated latex particles. The possibilities and limits of the method.
    Melliger EJ
    Thromb Diath Haemorrh; 1970 May; 23(2):211-27. PubMed ID: 4193323
    [No Abstract]   [Full Text] [Related]  

  • 31. Chicken fibrinogen and human fibrinogen. Comparative immunological studies.
    Ménaché D; Cesbron N; Guillin MC; Schlegel N
    Thromb Diath Haemorrh; 1973 Sep; 30(1):72-83. PubMed ID: 4132955
    [No Abstract]   [Full Text] [Related]  

  • 32. The half-life of plasmic degradation products of human fibrinogen in rabbits.
    Ardaillou N; Dray L; Budzynski AZ; Marder VJ; Larrieu MJ
    Thromb Haemost; 1977 Apr; 37(2):201-9. PubMed ID: 577624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contribution on the immunology of rabbit fibrinogen].
    Krantz S
    Acta Biol Med Ger; 1968; 21(3):385-96. PubMed ID: 4973966
    [No Abstract]   [Full Text] [Related]  

  • 34. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

  • 35. The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays.
    Molla A; Donati MB; Vermylen J
    J Clin Pathol; 1974 Jun; 27(6):473-9. PubMed ID: 4137968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assay of IgG and other human plasma proteins by quantitative inhibition of passive hemagglutination.
    Nusbacher J; Berkman EM; Wong KY; Kochwa S; Rosenfield RE
    J Immunol; 1972 Apr; 108(4):893-902. PubMed ID: 4623399
    [No Abstract]   [Full Text] [Related]  

  • 37. Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid.
    Clemmensen I; Andersen RB
    J Lab Clin Med; 1978 Nov; 92(5):678-89. PubMed ID: 712203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quantitative determination of D and E fibrinogen fragments using electroimmunodiffusion].
    Ferrari G; Fabucci C
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):221-4. PubMed ID: 828057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmin-antiplasmin complex formation during defibrase infusion in man.
    Collen D; Verstraete M
    Thromb Res; 1977 Sep; 11(3):417-20. PubMed ID: 144333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.